about
Small-molecule anti-inflammatory drug compositions for the treatment of asthma: a patent review (2013 - 2014).Lebrikizumab in the treatment of asthma.Benralizumab for the treatment of asthma.Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome.Asthma referrals: a key component of asthma management that needs to be addressed.Comparison of Interleukin-33 Serum Levels in Asthmatic Patients with a Control Group and Relation with the Severity of the Disease.
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
An update on biologic-based therapy in asthma.
@en
type
label
An update on biologic-based therapy in asthma.
@en
prefLabel
An update on biologic-based therapy in asthma.
@en
P2860
P356
P1433
P1476
An update on biologic-based therapy in asthma.
@en
P2093
Garry M Walsh
P2860
P304
P356
10.2217/IMT.13.118
P577
2013-11-01T00:00:00Z